Cancer Letters
Volume 290, Issue 2 , Pages 216-222 , 28 April 2010

Photodynamic therapy-driven induction of suicide cytosine deaminase gene

  • Jacek Bil

      Affiliations

    • Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland
    • ,
  • Pawel Wlodarski

      Affiliations

    • Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, 02-004 Warsaw, Poland
    • ,
  • Magdalena Winiarska

      Affiliations

    • Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland
    • ,
  • Zuzanna Kurzaj

      Affiliations

    • Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland
    • ,
  • Tadeusz Issat

      Affiliations

    • Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland
    • ,
  • Alicja Jozkowicz

      Affiliations

    • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland
    • ,
  • Barbara Wegiel

      Affiliations

    • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland
    • ,
  • Jozef Dulak

      Affiliations

    • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland
    • ,
  • Jakub Golab

      Affiliations

    • Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland
    • Institute of Physical Chemistry, Polish Academy of Sciences, Department 3, 01-224 Warsaw, Poland
    • Corresponding Author InformationCorresponding author. Address: Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 1A Banacha Str., F Building, 02-097 Warsaw, Poland. Tel.: +48 22 5992199; fax: +48 22 5992194.

Received 1 July 2009 ,Revised 16 September 2009 ,Accepted 17 September 2009.

References 

  1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J. Natl. Cancer Inst. 1998;90:889–905
  2. Tromberg BJ, Orenstein A, Kimel S, Barker SJ, Hyatt J, Nelson JS, et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 1990;52:375–385
  3. Zilberstein J, Bromberg A, Frantz A, Rosenbach-Belkin V, Kritzmann A, Pfefermann R, et al. Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor. Photochem. Photobiol. 1997;65:1012–1019
  4. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914–4921
  5. Reed MW, Miller FN, Wieman TJ, Tseng MT, Pietsch CG. The effect of photodynamic therapy on the microcirculation. J. Surg. Res. 1988;45:452–459
  6. Henderson BW, Owczarczak B, Sweeney J, Gessner T. Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation. Photochem. Photobiol. 1992;56:513–521
  7. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metast. Rev. 2007;26:225–239
  8. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001;93:266–276
  9. Zagorska A, Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 2004;51:563–585
  10. Weidemann A, Johnson RS. Biology of HIF-1α. Cell Death Differ. 2008;15:621–627
  11. Semenza GL. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 2003;3:721–732
  12. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000;60:4066–4069
  13. Mitra S, Cassar SE, Niles DJ, Puskas JA, Frelinger JG, Foster TH. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α. Mol. Cancer Ther. 2006;5:3268–3274
  14. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, et al. Induction of hypoxia-inducible factor-1α overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett. 2006;244:182–189
  15. Koukourakis MI, Giatromanolaki A, Skarlatos J, Corti L, Blandamura S, Piazza M, et al. Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001;61:1830–1832
  16. Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H, et al. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Human Gene Ther. 2004;15:553–561
  17. Luna MC, Chen X, Wong S, Tsui J, Rucker N, Lee AS, et al. Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter. Cancer Res. 2002;62:1458–1461
  18. Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 1993;53:4619–4626
  19. Szokalska A, Makowski M, Nowis D, Wilczynski GM, Kujawa M, Wojcik C, et al. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res. 2009;69:4235–4243
  20. Powers WE, Tolmach LJ. Demonstration of an anoxic component in a mouse tumor-cell population by in vivo assay of survival following irradiation. Radiology. 1964;83:328–336
  21. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer. 2008;8:425–437
  22. Stanley JA, Shipley WU, Steel GG. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Brit. J. Cancer. 1977;36:105–113
  23. Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst. 2007;99:1441–1454
  24. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 1987;47:3110–3114
  25. Golab J, Olszewska D, Mroz P, Kozar K, Kaminski R, Jalili A, et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin. Cancer Res. 2002;8:1265–1270
  26. White L, Gomer CJ, Doiron DR, Szirth BC. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Brit. J. Cancer. 1988;57:455–458
  27. Foster TH, Murant RS, Bryant RG, Knox RS, Gibson SL, Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 1991;126:296–303
  28. Klimova T, Chandel NS. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008;15:660–666
  29. Pierrefite-Carle V, Baque P, Gavelli A, Mala M, Chazal M, Gugenheim J, et al. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J. Natl. Cancer Inst. 1999;91:2014–2019

PII: S0304-3835(09)00600-4

doi: 10.1016/j.canlet.2009.09.012

Cancer Letters
Volume 290, Issue 2 , Pages 216-222 , 28 April 2010

Article Tools

* Image Usage & Resolution